Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Boston University Clinical and Translational Science Institute (CTSI), Boston, Massachusetts, U.S.A.
Laryngoscope. 2020 Sep;130(9):2160-2165. doi: 10.1002/lary.28321. Epub 2019 Oct 25.
Competing risk analysis is a powerful assessment for cancer risk factors and covariates. This method can better elucidate insurance status and other social determinants of health covariates in oral cavity cancer treatment, survival, and disparities.
Retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database.
Data regarding patient characteristics, clinical stage at diagnosis, treatment, and survival data for 20,271 patients diagnosed with oral cavity cancer was extracted from the SEER 18 Regs Research Data including Hurricane Katrina Impacted Louisiana Cases from 1973 to 2014. All statistical analyses were performed using SAS 9.5 (SAS Institute Inc., Cary, NC). The Fine-Gray method for assessing impact, risk, and covariates was employed.
Medicaid patients presented with later stage disease, larger tumor size, more distant metastases, and more lymph node involvement at diagnosis compared to insured patients. Medicaid patients were less likely to receive cancer-directed surgery. Medicaid status was also associated with worse cancer-specific survival (subhazard ratios 1.87, 95% confidence interval 1.72-2.04, P < .0001) after adjustment for all covariates.
This is the first study examining specifically how Medicaid status and social determinants of health covariates impact oral cavity cancer treatment and outcomes and is the first using methods validated for complex covariates. Patients with Medicaid present with more extensive oral cavity disease burden are less likely to receive definitive therapy and have significantly worse overall survival than those with other forms of insurance. This better identifies disparities and the need for improving health literacy, specifically for the at-risk Medicaid population, and can guide clinicians.
NA Laryngoscope, 130:2160-2165, 2020.
竞争风险分析是评估癌症风险因素和协变量的有力方法。这种方法可以更好地阐明口腔癌治疗、生存和差异中的保险状况和其他健康社会决定因素。
使用监测、流行病学和最终结果(SEER)数据库进行回顾性队列研究。
从 1973 年至 2014 年的 SEER 18 注册研究数据中提取了 20271 名口腔癌患者的患者特征、诊断时临床分期、治疗和生存数据,包括卡特里娜飓风受灾的路易斯安那州病例。所有统计分析均使用 SAS 9.5(SAS 研究所,卡里,NC)进行。采用 Fine-Gray 法评估影响、风险和协变量。
与有保险的患者相比,医疗补助患者在诊断时表现出更晚期的疾病、更大的肿瘤大小、更远的转移和更多的淋巴结受累。医疗补助患者接受癌症定向手术的可能性较小。调整所有协变量后,医疗补助状况也与癌症特异性生存较差相关(亚危险比 1.87,95%置信区间 1.72-2.04,P<0.0001)。
这是第一项专门研究医疗补助状况和健康社会决定因素如何影响口腔癌治疗和结局的研究,也是第一项使用针对复杂协变量进行验证的方法的研究。患有医疗补助的患者口腔疾病负担更重,更不可能接受确定性治疗,总生存率明显低于其他形式保险的患者。这更好地确定了差异和改善健康素养的必要性,特别是对于高风险的医疗补助人群,并可以指导临床医生。
无喉镜,130:2160-2165,2020。